dc.contributor.author | Ruiz-Nodar, Juan M. | |
dc.contributor.author | Hoekstra, James | |
dc.contributor.author | Rao, Sunil V. | |
dc.contributor.author | Ruzyllo, Witold | |
dc.contributor.author | Sabate, Manel | |
dc.contributor.author | Widimsky, Petr | |
dc.contributor.author | Kiss, Robert Gabor | |
dc.contributor.author | Navarro Estrada, Jose Luis | |
dc.contributor.author | Hod, Hanoch | |
dc.contributor.author | Kerkar, Prafulla | |
dc.contributor.author | Guneri, Sema | |
dc.contributor.author | Ruda, Mikhail | |
dc.contributor.author | Nicolau, Jose Carlos | |
dc.contributor.author | Cavallini, Claudio | |
dc.contributor.author | Ebrahim, Iftikhar | |
dc.contributor.author | Petrov, Ivo | |
dc.contributor.author | Kim, Jae-Hyung | |
dc.contributor.author | Jeong, Myung-Ho | |
dc.contributor.author | Ramos Lopez, Gabriel Arturo | |
dc.contributor.author | Laanmets, Peep | |
dc.contributor.author | Kovar, Frantisek | |
dc.contributor.author | Gaudin, Christophe | |
dc.contributor.author | Fanouillere, Karen C. | |
dc.contributor.author | Minini, Pascal | |
dc.contributor.author | Hoffman, Elaine B. | |
dc.contributor.author | Moryusef, Angele | |
dc.contributor.author | Wiviott, Stephen D. | |
dc.contributor.author | Sabatine, Marc S. | |
dc.contributor.author | Sezer, Murat | |
dc.contributor.author | Steg, Philippe Gabriel | |
dc.contributor.author | Mehta, Shamir R. | |
dc.contributor.author | Pollack, Charles V. | |
dc.contributor.author | Bode, Christoph | |
dc.contributor.author | Cohen, Marc | |
dc.contributor.author | French, William J. | |
dc.date.accessioned | 2021-03-05T21:32:08Z | |
dc.date.available | 2021-03-05T21:32:08Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Steg P. G. , Mehta S. R. , Pollack C. V. , Bode C., Cohen M., French W. J. , Hoekstra J., Rao S. V. , Ruzyllo W., Ruiz-Nodar J. M. , et al., "Anticoagulation With Otamixaban and Ischemic Events in Non-ST-Segment Elevation Acute Coronary Syndromes The TAO Randomized Clinical Trial", JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, cilt.310, ss.1145-1155, 2013 | |
dc.identifier.issn | 0098-7484 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_d95327df-5b1a-4dde-9cc3-d45e9f993e7b | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/143356 | |
dc.identifier.uri | https://doi.org/10.1001/jama.2013.277165 | |
dc.description.abstract | IMPORTANCE The optimal anticoagulant for patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) managed with an invasive strategy remains controversial. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.title | Anticoagulation With Otamixaban and Ischemic Events in Non-ST-Segment Elevation Acute Coronary Syndromes The TAO Randomized Clinical Trial | |
dc.type | Makale | |
dc.relation.journal | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | |
dc.contributor.department | Universite De Paris-Dauphine , , | |
dc.identifier.volume | 310 | |
dc.identifier.issue | 11 | |
dc.identifier.startpage | 1145 | |
dc.identifier.endpage | 1155 | |
dc.contributor.firstauthorID | 210999 | |